ISPOR 15th Annual European Congress, Berlin
Berlin, Germany 3 - 7 November 2012
This year's 15th Annual ISPOR European congress took place at the ICC Berlin, 3-7 November. Representing Access Partnership were Mike Mallinson, President, Rob White, Global Director of Market Access, Dr Shri Rao Mukku, Global Director of Pricing and Reimbursement and Founding Directors Mary Assimakopoulos and Mark Jeffery. This event provided the first opportunity for Access Partnership to demonstrate their extensive knowledge and experience within market access to the healthcare industry. The Consultants found the event extremely interesting and worthwhile, allowing plenty of networking opportunities and engaging conversation with thought leaders from around the world.
ISPOR Europe 2012 Papers
Posters and papers presented by Access Partnership at ISPOR Europe 2012
Drivers of pricing and market access decisions - Examples in selected countries
How will the new NHS changes in England impact the implementation of risk sharing schemes for oncology treatments
How will the new NHS decentralised reforms impact on access to medicines in England?
Orphan drug pricing and access - current situation and future trends
Announcing a new strategic market access consultancy
Research Partnership is today launching a new market access consultancy called "Access Partnership".
Research Partnership is today launching a new market access consultancy called "Access Partnership" which will provide services to the pharmaceutical, biotech and medtech industries.
Access Partnership will work with manufacturers to help them develop the value strategy for their technologies, including pricing, market access and payer engagement, in order to achieve commercial success for their innovations. The company's global headquarters are based in London, UK, with other offices in the US and Singapore.